|
Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Gender, Obesity, C-Reactive Protein, and Oxidative Stress conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical research trials and Gender, Obesity, C-Reactive Protein, and Oxidative Stress healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Gender, Obesity, C-Reactive Protein, and Oxidative Stress. Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Gender, Obesity, C-Reactive Protein, and Oxidative Stress clinical trial. Human subjects often receive the most effective healthcare possible for their Gender, Obesity, C-Reactive Protein, and Oxidative Stress condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Gender, Obesity, C-Reactive Protein, and Oxidative Stress  Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
For Condition: Cardiovascular Disease
Status: Not yet recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.
Details: Participants will be given 1000 mg vitamin C or 800 IU vitamin E daily for 60 days.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Nonsmoker and not passively exposed - Males and females 18 year and older - Able to take vitamin supplements - Able to take acetominophen instead of aspirin or NSAIDs during the study Exclusion criteria: - Pregnancy or lactation - History of ever smoking or passive smoke exposure in the last year - Active liver disease; history of HIV/AIDS, diabetes, kidney stones, hemochromatosis, or autoimmune diseases; heart disease, stroke, or cancer in the last 5 years - User of prescribed anti-inflammatory or lipid-lowering medications, oral contraceptives, hormone replacement therapy, or blood-thinning drugs - User of iron supplements or vitamin E at 600 IU per day or more - Consumption of more than 2 alcoholic beverages per day
Total Enrollment: 400
Location and Contact Information:
University of California, Berkeley School of Public Health
Berkeley, California, 94720-7360
United States
Gladys Block 510-643-7896
Additional Information:
Study ID Numbers: 62378DK;
Study Start Date: April 2004
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00079963
Other Cardiovascular Disease Studies:
1. Does prophylactic coronary artery revascularization for high risk patients reduce long-term risk of mortality
2. Fitness and Daily Function in Adults
3. Angiomax in Patients with HIT/HITTS Type II Undergoing CPB
4. Effects of Exercise on patients with Hemiparetic Stroke
5. Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
Related Studies:
Other Cardiovascular Disease Clinical Trials
Other California Clinical Trials
Other Berkeley Clinical Trials
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
|
|
|
|
|
|
|
|
